50242015001 — Ocrelizumab 600 Mg Vial (pa)
$21,014
All-payer median here
$19,052
Cash / self-pay here
24
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.